Recurrent chromosomal translocations can drive oncogenesis, but how they form has remained elusive. Now, Chiarle et al. (2011) and Klein et al. (2011) characterize the genome-wide spectrum of translocations that form from a single double-stranded break, revealing that specific loci have an intrinsic predisposition for frequent chromosomal rearrangements.
In the face of damage from everyday metabolic processes or external ionizing radiation, a cell must maintain chromosomal integrity. The most dangerous event that it can face is a DNA doublestrand break (DSB), which can lead to chromosomal translocations (Mills et al., 2003) . Chromosomal translocations are a common feature of many cancers, with specific, recurrent translocations occurring in nearly 40% of all human tumors (Shaffer and Pandolfi, 2006) .
Recurrent translocations can promote tumorigenesis by creating novel gene products or by altering the regulation of genes involved in cell proliferation and differentiation. For example, the Bcr/Abl translocation, observed in 90% of chronic myelogenous leukemia cases, creates a novel oncogene that is sufficient to transform cells in vitro. Why do recurrent translocations occur so frequently? They could result from random and rare events that are subsequently selected due to their proliferative potential. Alternatively, molecular processes could predispose specific loci to engage frequently in translocations. In this issue, Klein et al. and Chiarle et al. present powerful new methods to address such questions by capturing the genome-wide landscape of translocations (a translocatome), which result from a single defined DSB in primary cells in the absence of confounding effects of growth selection (Chiarle et al., 2011; Klein et al., 2011) .
The two methods induce a DSB at a defined position in the genome. After allowing the cells to repair this DSB for a relatively short time, translocation junctions between the induced DSB and endogenous DSBs are identified by PCR amplification and deep sequencing. Both studies find that most cells repair the induced DSB by rejoining the ends without causing major genomic rearrangements. However, a significant fraction of cells join the induced DSB ends with endogenous DSBs elsewhere in the genome, creating intra-and interchromosomal rearrangements.
Though these technologies can be widely applied to any cellular system, both groups use them to examine genomic rearrangements in murine B cells. These immune cells can give rise to lymphomas as a result of a recurrent interchromosomal translocation between the c-myc gene and the IgH locus (Kü ppers and Dalla-Favera, 2001) . In these two studies, the authors conditionally introduce a DSB at either the IgH or the c-myc locus in B cells activated for class switch recombination (CSR), a process that generates a spectrum of endogenous DSBs. They find that B cells minimize the risk of deleterious translocations from all of these DSBs by repairing almost half of the induced DSBs locally, within 1 kb of the original break site. Even within 100 kb of the break site, some junctions can be attributed to the local repair process of resection and resealing. Outside of local repair, however, the authors observe a multitude of translocation partners of c-myc and IgH that could generate almost every chromosomal aberration imaginable, including di-centric and a-centric chromosomes.
This diversity shows the power of capturing an early, unselected translocatome, as many of these rearrangements would have been lost if cells were required to undergo cell division. Importantly, these studies reveal that the frequency of translocations derived from a single DSB is 0.4%-1%. In a living organism, where millions of B cells per day experience endogenous DSBs during CSR, the observed translocation rate predicts that nearly 10 3 cells per day could form inadvertent translocations.
With distinct yet similar experimental protocols, these two studies paint a picture of some of the underlying mechanisms that predispose certain regions to translocations in B cells (Figure 1 ). For instance, both groups find that translocations occur more frequently on the chromosome carrying the induced break, even up to 50 Mb away. Such a phenomenon cannot be explained by local repair activity but, rather, suggests that translocations between pairs of DSBs occurring on the same chromosome are strongly preferred over interchromosomal events. Given that loci on the same chromosome tend to be located closer to each other in the nucleus than loci on different chromosomes, the spatial organization of the genome may directly impact the formation of translocations.
Despite the enrichment for intrachromosomal translocations, the authors find that interchromosomal translocations occur frequently, comprising 60% of the nonlocal repair events. Some chromosomal regions translocate so frequently that they are classified as ''hot spots.'' Among these, the c-myc/IgH translocation is among the most frequent, regardless of whether the original break was introduced at c-myc or IgH. What mechanisms might explain the recurrent formation of certain translocations? Both studies find that many hot spots depend on activation-induced cytidine deaminase (AID). AID initiates CSR and somatic hypermutation by inducing DNA damage at immunoglobulin (Ig) loci . Importantly, Klein et al. (2011) and Chiarle et al. (2011) show that this enzyme not only acts at canonical target loci, but also at additional sites throughout the genome, initiating DSBs that can lead to translocations. Thus, B cells pay a price for their programmed ability to rearrange Ig loci by acquiring DNA damage elsewhere in the genome.
Even in the absence of AID-dependent DSBs, there are numerous nonrandom translocations throughout the genome. Both studies find that translocations are much more likely to happen near transcription start sites (TSSs) of actively transcribed genes. Though this effect is pronounced when AID is present (AID induces DSBs at exposed cytosines revealed by stalled RNA polymerases; Pavri et al., 2010) , transcription alone creates a risk of DSBs.
Together, these studies show that transcription, the generation of breaks by AID, and physical linkage along the DNA all affect translocation frequency (Figure 1) . Importantly, the presence of translocation hot spots in the absence of selection suggests that recurrent translocations observed in disease may have mechanistic causes rather than solely being observed due to selection. Recurrent translocations in cancer may result from intrinsic mechanisms and thus may or may not be drivers of disease. The broad distribution of translocations, along with the likelihood that these rearrangements occur near gene promoters, explains the high risk of acquiring novel gene products and translocation-driven cancers.
These studies highlight the molecular processes that lead to formation of DSBs at particular genomic sites. However, for a translocation to occur, two DSBs must also come into close proximity. How and when this contact occurs has long been debated in terms of two contrasting models. The ''contact first'' model proposes that only regions of chromosomes already in contact prior to DSB formation can form translocations, whereas the ''breakage first'' model hypothesizes that DSBs can move in the nuclear space to contact translocation partners (Meaburn et al., 2007) . The results of the studies from Klein et al. (2011) and Chiarle et al. 2011 suggest that spatial genome organization may affect translocation frequency, but neither study resolves which of the two models applies. The tendency of translocations to occur on the same chromosome as the engineered break site suggests that close spatial proximity can contribute to formation of specific translocations. Indeed, other studies have reported that IgH and c-myc are closely juxtaposed even before a DSB occurs (Roix et al., 2003) , possibly facilitating translocation formation when DSBs are introduced. However, the extent to which loci move, especially when CSR and somatic hypermutation are activated, remains unresolved. We now have the ability to comprehensively determine the initiating translocatomes; combining such techniques with other genome-wide assays that probe chromatin state and spatial conformation (Lieberman-Aiden et al., 2009 ) will contribute to a better understanding of the mechanisms that lead to recurrent formation of disease-causing genomic rearrangements. 
. Factors Predisposing Loci to Double-Strand Breaks and Translocations
Genome-wide translocation mapping identifies translocations that form when a DNA double-strand break (DSB) is artificially introduced in a defined location by the I-SceI meganuclease (center). The majority of induced DSBs are repaired locally, but many form translocation junctions with endogenous DSBs. These endogenous DSBs, often mediated by AID activity, occur at transcription start sites (left), class switch recombination sites (top), and elsewhere throughout the genome (right).
In this issue of Cell, Gabut and colleagues (2011) identify a new splice variant of FOXP1 that directly regulates the expression of pluripotency genes. It endows human embryonic stem cells with their pluripotent nature and is required for the reprogramming of somatic cells to induced pluripotent stem cells.
The past few years have seen remarkable progress in our understanding of the mechanistic basis of pluripotency, including the identification of key factors required for maintaining the pluripotent state of human embryonic stem cells (ESCs) (Chen et al., 2008; Kim et al., 2008; Silva et al., 2009) . Moreover, one of the great breakthroughs of this decade was the discovery that a only few critical transcriptions factors, such as the combination of Oct4, Sox2, Klf4, and c-Myc, are sufficient to reprogram somatic cells into induced pluripotent stem (iPS) cells (Takahashi et al., 2007) . These factors appear to activate a transcriptional network that endows cells with pluripotency (Samavarchi-Tehrani et al., 2010) , but gene expression can be regulated by numerous processes other than transcription, including chromatin modifications, RNA stability, and pre-RNA splicing. How these processes contribute to pluripotency has been largely understudied in human ESCs. Now in this issue of Cell, Gabut et al. (2011) break this field wide open by identifying an alternative splicing ''switch'' at the top of the pluripotency transcriptional network.
Alternative splicing-the process by which exons can be joined together in different patterns such that a single gene can give rise to multiple transcripts-is known to regulate key developmental decisions in a number of systems (Nilsen and Graveley, 2010) . Perhaps the best known example is the sex-determination pathway in Drosophila (Salz, 2011) . This pathway consists of five genes encoding premRNAs that are spliced in a sex-specific manner ( Figure 1A) . The genes are organized in a hierarchy in which the splicing of an upstream gene regulates that of downstream genes. The genes at the bottom of this hierarchy, dsx (doublesex) and fru (fruitless), encode transcription factors, and the male-specific and female-specific protein variants of each factor regulate distinct sets of target genes. Thus, these regulated splicing events act in a switch-like manner to specify nearly all aspects of sex determination and courtship behavior.
To explore the role of alternative splicing in human ESC pluripotency, Gabut et al. use microarrays that can detect different splicing variants. These experiments reveal numerous splicing events that change as human ESCs differentiate into neural precursor cells, including one in the FOXP1 gene. This event involves a previously unannotated exon that is included in human ESCs but skipped in differentiated cells ( Figure 1B) . Strikingly, the exon's sequence and its stem cell specificity is conserved in mouse, suggesting that it might play a significant role in stem cell biology.
FOXP1 encodes a member of the forkhead family of transcription factors, which recognize particular DNA sequences through a ''forkhead domain.'' FOXP1 is an essential gene that is broadly expressed and required for the establishment of specific cell types. Fusions of FOXP1 with other genes or loss of FOXP1 function are associated with many different types of cancer (Wang et al., 2004; Dasen et al., 2008) . Intriguingly, the
